Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

A Engert; V Diehl; A Pluetschow; HT Eich; R Herrmann; B Doerken; L Kanz; Richard Greil; J Markova; M Fuchs; P Borchmann; HK Mueller-Hermelink; RP Mueller

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

A Engert, V Diehl, A Pluetschow, HT Eich, R Herrmann, B Doerken, L Kanz, Richard Greil, J Markova, M Fuchs, P Borchmann, HK Mueller-Hermelink, RP Mueller

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	716
Journal	BLOOD
Volume	114
Issue number	22
Publication status	Published - 2009
Event	51st annual meeting of the American Society of Hematology - New Orleans, LA, United States Duration: 5 Dec 2009 → 8 Dec 2009

1 Poster

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.
Engert, A., Diehl, V., Pluetschow, A., Eich, H., Herrmann, R., Doerken, B., Kanz, L., Greil, R., Markova, J., Fuchs, M., Borchmann, P., Mueller-Hermelink, H. & Mueller, R., 2009.
Research output: Contribution to conference › Poster

Cite this

Engert, A., Diehl, V., Pluetschow, A., Eich, HT., Herrmann, R., Doerken, B., Kanz, L., Greil, R., Markova, J., Fuchs, M., Borchmann, P., Mueller-Hermelink, HK., & Mueller, RP. (2009). Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma. BLOOD , 114(22), 716.

Engert, A ; Diehl, V ; Pluetschow, A et al. / Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma. In: BLOOD 2009 ; Vol. 114, No. 22. pp. 716.

@article{ae65441256794987a013955ef78c3057,

title = "Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.",

author = "A Engert and V Diehl and A Pluetschow and HT Eich and R Herrmann and B Doerken and L Kanz and Richard Greil and J Markova and M Fuchs and P Borchmann and HK Mueller-Hermelink and RP Mueller",

year = "2009",

language = "English",

volume = "114",

pages = "716",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "22",

note = "51st annual meeting of the American Society of Hematology ; Conference date: 05-12-2009 Through 08-12-2009",

}

Engert, A, Diehl, V, Pluetschow, A, Eich, HT, Herrmann, R, Doerken, B, Kanz, L, Greil, R, Markova, J, Fuchs, M, Borchmann, P, Mueller-Hermelink, HK & Mueller, RP 2009, 'Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.', BLOOD , vol. 114, no. 22, pp. 716.

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma. / Engert, A; Diehl, V; Pluetschow, A et al.
In: BLOOD , Vol. 114, No. 22, 2009, p. 716.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

AU - Engert, A

AU - Diehl, V

AU - Pluetschow, A

AU - Eich, HT

AU - Herrmann, R

AU - Doerken, B

AU - Kanz, L

AU - Greil, Richard

AU - Markova, J

AU - Fuchs, M

AU - Borchmann, P

AU - Mueller-Hermelink, HK

AU - Mueller, RP

PY - 2009

Y1 - 2009

M3 - Abstract (Journal)

SN - 0006-4971

VL - 114

SP - 716

JO - BLOOD

JF - BLOOD

IS - 22

T2 - 51st annual meeting of the American Society of Hematology

Y2 - 5 December 2009 through 8 December 2009

ER -

Engert A, Diehl V, Pluetschow A, Eich HT, Herrmann R, Doerken B et al. Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma. BLOOD . 2009;114(22):716.